Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
9.61
+0.02 (0.21%)
At close: Apr 28, 2026, 4:00 PM EDT
9.66
+0.05 (0.52%)
After-hours: Apr 28, 2026, 7:00 PM EDT
Biohaven Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Biohaven stock have an average target of 29.08, with a low estimate of 9.00 and a high estimate of 75. The average target predicts an increase of 202.60% from the current stock price of 9.61.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biohaven stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 6 | 6 | 5 | 5 |
| Buy | 5 | 4 | 5 | 5 | 5 | 5 |
| Hold | 4 | 5 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 15 | 15 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $14 → $17 | Strong Buy | Maintains | $14 → $17 | +76.90% | Apr 2, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $15 → $30 | Strong Buy | Maintains | $15 → $30 | +212.17% | Mar 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +4.06% | Mar 4, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $22 → $23 | Buy | Maintains | $22 → $23 | +139.33% | Mar 3, 2026 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $9 → $22 | Hold → Buy | Upgrades | $9 → $22 | +128.93% | Jan 21, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
40.36M
EPS This Year
-2.94
from -6.86
EPS Next Year
-2.45
from -2.94
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 105.0M | ||||||
| Avg | n/a | 40.4M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.09 | -1.65 | ||||||
| Avg | -2.94 | -2.45 | ||||||
| Low | -3.87 | -3.58 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.